Facing Potential Shareholder Suit And SEC Inquiry In U.S., China Sky One Medical Tries To Reassure Investors
This article was originally published in PharmAsia News
Executive Summary
BEIJING - While facing a potential shareholders' suit for possible violation of U.S. laws, the leadership of China Sky One Medical Inc. sought to reassure investors by disclosing a rise in earnings for 2010 and inviting investors to visit the firm's headquarters in Harbin, an ice-covered Chinese city that borders Russia's Siberia
You may also be interested in...
Chinese Pharma Cracking The U.S. Market Via Reverse Mergers Draw Attention From Authorities
HONG KONG - A number of Chinese companies publicly traded in the U.S., including several in the pharmaceutical space, have come under the spotlight in the last 18 months after getting to market through reverse mergers
Chinese Pharma Cracking The U.S. Market Via Reverse Mergers Draw Attention From Authorities
HONG KONG - A number of Chinese companies publicly traded in the U.S., including several in the pharmaceutical space, have come under the spotlight in the last 18 months after getting to market through reverse mergers
China Sky One's Leaders Aim To Derail Potential Shareholders' Suit Headed By California Law Firm
BEIJING - Just weeks after alleging that U.S. media reports constituted "reckless criticism and attacks" for suggesting that China Sky One Medical misreported earnings, the Chinese firm has now confirmed that it filed inaccurate revenue statements with Chinese commercial authorities